BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 31855325)

  • 1. Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.
    Grambozov B; Wolf F; Kaiser J; Wass R; Fastner G; Gaisberger C; Rettenbacher L; Studnicka M; Pirich C; Sedlmayer F; Zehentmayr F
    Thorac Cancer; 2020 Feb; 11(2):369-378. PubMed ID: 31855325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.
    Torre-Bouscoulet L; Muñoz-Montaño WR; Martínez-Briseño D; Lozano-Ruiz FJ; Fernández-Plata R; Beck-Magaña JA; García-Sancho C; Guzmán-Barragán A; Vergara E; Blake-Cerda M; Gochicoa-Rangel L; Maldonado F; Arroyo-Hernández M; Arrieta O
    Respir Res; 2018 Apr; 19(1):72. PubMed ID: 29690880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.
    Berry MF; Yang CJ; Hartwig MG; Tong BC; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2015 Jul; 100(1):271-6. PubMed ID: 25986099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years.
    Kim JS; Kim EJ; Jang JG; Hong KS; Ahn JH
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7275-7283. PubMed ID: 36912944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative DLco and FEV
    Kim T; Jeon YJ; Lee H; Kim TH; Park SY; Kang D; Hong YS; Lee G; Lee J; Shin S; Cho JH; Choi YS; Kim J; Cho J; Zo JI; Shim YM; Kim HK; Park HY
    Sci Rep; 2024 Mar; 14(1):6117. PubMed ID: 38480929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life.
    Ahn J; Yeghiaian-Alvandi R; Hegi-Johnson F; Browne LH; Graham PH; Chin Y; Gee H; Vinod S; Ludbrook J; Last A; Dwyer P; Ong A; Aherne N; Azzi M; Hau E
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1213-1221. PubMed ID: 37482136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II).
    Bucknell NW; Hardcastle N; Bressel M; Moore A; Montgomery R; Murnane A; Mai GT; Ball D; Kron T; Siva S
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):944-951. PubMed ID: 37871885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term pulmonary function in survivors of childhood cancer.
    Armenian SH; Landier W; Francisco L; Herrera C; Mills G; Siyahian A; Supab N; Wilson K; Wolfson JA; Horak D; Bhatia S
    J Clin Oncol; 2015 May; 33(14):1592-600. PubMed ID: 25847925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of surgical approach on 90-day mortality after lung resection for nonsmall cell lung cancer in high-risk operable patients.
    Etienne H; Pagès PB; Iquille J; Falcoz PE; Brouchet L; Berthet JP; Le Pimpec Barthes F; Jougon J; Filaire M; Baste JM; Anne V; Renaud S; D'Annoville T; Meunier JP; Jayle C; Dromer C; Seguin-Givelet A; Legras A; Rinieri P; Jaillard-Thery S; Margot V; Thomas PA; Dahan M; Mordant P
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38259816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Textural analysis and lung function study: Predicting lung fitness for radiotherapy from a CT scan.
    Phillips I; Ezhil V; Hussein M; South C; Nisbet A; Alobaidli S; Prakash V; Ajaz M; Wang H; Evans P
    BJR Open; 2019; 1(1):20180001. PubMed ID: 33178905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical consideration of assessment methods for clinically significant changes of mental distress after psycho-oncological interventions.
    Vaganian L; Bussmann S; Gerlach AL; Kusch M; Labouvie H; Cwik JC
    Int J Methods Psychiatr Res; 2020 Jun; 29(2):e1821. PubMed ID: 32090408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer.
    Shin S; Choi YS; Jung JJ; Im Y; Shin SH; Kang D; Cho JH; Kim HK; Kim J; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Lee G; Cho J; Lee HY; Park HY
    Respir Res; 2020 Jan; 21(1):13. PubMed ID: 31924201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that Influence the Need to Start Adaptive Radiotherapy.
    Roby NM; Hassan M; Aboelkasem MA; Kamaleldin M; Ali AS
    J Immunother Precis Oncol; 2024 Feb; 7(1):18-23. PubMed ID: 38327756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial.
    Ghassemi N; Castillo R; Castillo E; Jones BL; Miften M; Kavanagh B; Werner-Wasik M; Miller R; Barta JA; Grills I; Leiby BE; Guerrero T; Rusthoven CG; Vinogradskiy Y
    Radiother Oncol; 2023 Oct; 187():109821. PubMed ID: 37516361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of four radiotherapy techniques for stage III non‑small cell lung cancer.
    Li C; Luo H; Song W; Hu Y; Li J; Cai Z
    Oncol Lett; 2023 Aug; 26(2):347. PubMed ID: 37427336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL
    Stana M; Grambozov B; Karner J; Gollner I; Gaisberger C; Ruznic E; Zellinger B; Moosbrugger R; Studnicka M; Fastner G; Sedlmayer F; Zehentmayr F
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
    Wass R; Hochmair M; Kaiser B; Grambozov B; Feurstein P; Weiß G; Moosbrugger R; Sedlmayer F; Lamprecht B; Studnicka M; Zehentmayr F
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon Monoxide Diffusing Capacity (DL
    Stana M; Grambozov B; Gaisberger C; Karner J; Ruznic E; Berchtold J; Zellinger B; Moosbrugger R; Studnicka M; Fastner G; Sedlmayer F; Zehentmayr F
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in DNA repair gene NEIL1 associated with radiation pneumonitis risk in lung cancer patients.
    Zheng Y; Zheng L; Yu J; Jiang M; Zhang S; Cai X; Zhu M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1698. PubMed ID: 34105905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.